Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 9
2021 8
2022 12
2023 4
2024 2
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration.
Nunes MC, Chauvel C, Raboni SM, López-Labrador FX, Andrew MK, Badar N, Baillie V, Bal A, Baral K, Baumeister E, Boutros C, Burtseva E, Coulibaly D, Cowling B, Danilenko D, Dbaibo G, Destras G, Dia N, Drăgănescu AC, Giamberardino HIG, Gomez-Camargo D, Josset L, Koul PA, Kyncl J, Laguna-Torres VA, Launay O, Nugyen LBL, McNeil S, Medić S, Mira-Iglesias A, Mironenko A, Nitsch-Osuch A, Orrico-Sánchez A, Otieno NA, Regue H, Ruiz-Palacios GM, Salah AB, Salman M, Săndulescu O, Simon V, Sominina A, Sordillo E, Tanriover MD, Unal S, van Bakel H, Vanhems P, Zhang T, Commaille-Chapus C, Hunsinger C, Bresee J, Lina B, McCauley JW, Ortiz JR, Viboud C, Zhang W, Torcel-Pagnon L, Mahe C, Chaves SS. Nunes MC, et al. Among authors: destras g. Influenza Other Respir Viruses. 2025 Mar;19(3):e70091. doi: 10.1111/irv.70091. Influenza Other Respir Viruses. 2025. PMID: 40082217 Free PMC article.
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
Hites M, Massonnaud CR, Lapique EL, Belhadi D, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Moing VL, Piroth L, Sellier P, Lescure X, Trøseid M, Clevenbergh P, Dalgard O, Gallien S, Gousseff M, Loubet P, Vardon-Bounes F, Visée C, Belkhir L, Botelho-Nevers É, Cabié A, Kotanidou A, Lanternier F, Rouveix-Nordon E, Silva S, Thiery G, Poignard P, Carcelain G, Diallo A, Mercier N, Terzic V, Bouscambert-Duchamp M, Gaymard A, Trabaud MA, Destras G, Josset L, Billard N, Han TH, Guedj J, Couffin-Cadiergues S, Dechanet A, Delmas C, Esperou H, Fougerou-Leurent C, Mestre SL, Métois A, Noret M, Bally I, Dergan-Dylon S, Tubiana S, Kalif O, Bergaud N, Leveau B, Eustace J, Greil R, Hajdu E, Halanova M, Paiva JA, Piekarska A, Rodriguez Baño J, Tonby K, Trojánek M, Tsiodras S, Unal S, Burdet C, Costagliola D, Yazdanpanah Y, Peiffer-Smadja N, Mentré F, Ader F; DisCoVeRy study group. Hites M, et al. Among authors: destras g. J Infect. 2024 Mar;88(3):106120. doi: 10.1016/j.jinf.2024.106120. Epub 2024 Feb 16. J Infect. 2024. PMID: 38367705 Free article. No abstract available.
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024.
Moisan A, Regue H, Rahou Y, Gaymard A, Oblette A, Avon L, Bergaud N, Chalvignac R, Le Hingrat Q, Burrel S, Jary A, Colson P, Cappy P, Deroche L, Brodard V, Pronier C, Alessandri-Gradt E, Salmona M, Chollet L, Trémeaux P, Handala L, Fourati S, Lina B, Casalegno JS; ANRS-MIE Technology Working Group; Rameix-Welti MA, Josset L, Bal A. Moisan A, et al. Clin Microbiol Infect. 2025 Apr;31(4):647-650. doi: 10.1016/j.cmi.2024.12.018. Epub 2024 Dec 24. Clin Microbiol Infect. 2025. PMID: 39725080 No abstract available.
Type I IFN immunoprofiling in COVID-19 patients.
Trouillet-Assant S, Viel S, Gaymard A, Pons S, Richard JC, Perret M, Villard M, Brengel-Pesce K, Lina B, Mezidi M, Bitker L, Belot A; COVID HCL Study group. Trouillet-Assant S, et al. J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29. J Allergy Clin Immunol. 2020. PMID: 32360285 Free PMC article. No abstract available.
Novel SARS-CoV-2 Variant Derived from Clade 19B, France.
Fourati S, Decousser JW, Khouider S, N'Debi M, Demontant V, Trawinski E, Gourgeon A, Gangloff C, Destras G, Bal A, Josset L, Soulier A, Costa Y, Gricourt G, Lina B, Lepeule R, Pawlotsky JM, Rodriguez C. Fourati S, et al. Among authors: destras g. Emerg Infect Dis. 2021 May;27(5):1540-1543. doi: 10.3201/eid2705.210324. Emerg Infect Dis. 2021. PMID: 33900195 Free PMC article.
A Short COVID-19 Outbreak in an Isolated Pacific Island: A Retrospective Study.
Couteaux C, Gahetau E, Robic G, Houillon D, Lenei F, Riou O, Lhomme V, Josset L, Destras G, Bal A, Hugues I, Roche B, Worms B, Etard JF. Couteaux C, et al. Among authors: destras g. Asia Pac J Public Health. 2022 Jul;34(5):586-588. doi: 10.1177/10105395221106863. Epub 2022 Jun 15. Asia Pac J Public Health. 2022. PMID: 35703398 No abstract available.
Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients.
Roy A, Saade C, Josset L, Clément B, Morfin F, Destras G, Valette M, Icard V, Billaud G, Oblette A, Debombourg M, Garrigou C, Brengel-Pesce K, Generenaz L, Saker K, Hernu R, Pozzetto B, Lina B, Trabaud MA, Trouillet-Assant S, Bal A. Roy A, et al. Among authors: destras g. J Med Virol. 2023 Aug;95(8):e28984. doi: 10.1002/jmv.28984. J Med Virol. 2023. PMID: 37503561
37 results